Transfusion in Cardiac Valve Surgery

Launched by GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL · Mar 26, 2024

Keywords

ClinConnect Summary

This clinical trial, called "Transfusion in Cardiac Valve Surgery," is looking to find the best amount of blood transfusion needed for patients undergoing heart valve surgery with a heart-lung machine (called cardiopulmonary bypass). The study will randomly place participants into two groups: one group will receive a smaller amount of blood (restrictive transfusion), while the other will receive a larger amount (liberal transfusion). Researchers will then compare the outcomes for both groups to see which approach is more effective and safer.

To be eligible for this trial, you need to be between the ages of 18 and 80 and scheduled for heart valve surgery that does not involve other major heart procedures, like bypass surgery. If you are pregnant, have certain health issues, or cannot receive blood for personal or religious reasons, you may not be able to participate. If you join the study, you can expect to receive the treatment as planned and be monitored closely for your health outcomes during and after the surgery. It’s important to note that this trial is not yet recruiting participants, so it’s still in the planning stages.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All cardiac valve surgical patients undergoing CPB, isolated valve procedures Informed consent obtained
• Exclusion Criteria:
• • Pregnant or maternal women Age less than 18 years or more than 80 years Undergo coronary artery bypass or large cardiac vessels procedure Emergencies Have been attended other researches Unable to receive blood for religious reasons Drug addict or malignant tumor patient